Cemex SAB de CV (NYSE:CX) Upgraded by Zacks Investment Research to “Hold”

Share on StockTwits

Zacks Investment Research upgraded shares of Cemex SAB de CV (NYSE:CX) from a sell rating to a hold rating in a report published on Tuesday, Zacks.com reports.

According to Zacks, “CEMEX is one of the largest cement companies in the world, with close to 78 million metric tons of production capacity. Through operating subsidiaries in four continents, they are engaged in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates and clinker. They are also the world’s leading producer of white cement and the world’s largest trader of cement and clinker. “

A number of other equities research analysts have also recently issued reports on the stock. HSBC cut shares of Cemex SAB de CV from a buy rating to a hold rating in a research report on Wednesday, September 11th. ValuEngine raised shares of Cemex SAB de CV from a sell rating to a hold rating in a report on Wednesday, October 2nd. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of $6.00.

Shares of NYSE:CX opened at $3.52 on Tuesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.69 and a quick ratio of 0.50. The business’s fifty day moving average price is $3.84 and its two-hundred day moving average price is $3.85. Cemex SAB de CV has a fifty-two week low of $2.82 and a fifty-two week high of $5.63. The stock has a market capitalization of $5.59 billion, a price-to-earnings ratio of 10.06 and a beta of 1.43.

Cemex SAB de CV (NYSE:CX) last issued its quarterly earnings data on Thursday, October 24th. The construction company reported $0.11 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.05). Cemex SAB de CV had a net margin of 2.51% and a return on equity of 1.78%. The company had revenue of $3.49 billion for the quarter. Research analysts expect that Cemex SAB de CV will post 0.28 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Virtus ETF Advisers LLC bought a new stake in Cemex SAB de CV during the 2nd quarter worth about $26,000. Golden State Wealth Management LLC raised its stake in shares of Cemex SAB de CV by 121.9% in the second quarter. Golden State Wealth Management LLC now owns 7,281 shares of the construction company’s stock worth $30,000 after acquiring an additional 4,000 shares during the last quarter. Howard Financial Services LTD. bought a new position in shares of Cemex SAB de CV in the third quarter worth about $42,000. TT International acquired a new position in shares of Cemex SAB de CV during the second quarter worth approximately $46,346,000. Finally, Traynor Capital Management Inc. acquired a new position in shares of Cemex SAB de CV during the third quarter worth approximately $43,000. Institutional investors and hedge funds own 33.53% of the company’s stock.

Cemex SAB de CV Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, clinker, and other construction materials. The company also offers various complementary construction products, including asphalt products; concrete blocks and roof tiles; architectural products; concrete pipes for storm and sanitary sewers applications; and other precast products comprising rail products, concrete floors, box culverts, bridges, drainage basins, barriers, and parking curbs.

Featured Article: Investing in Dividend Stocks

Get a free copy of the Zacks research report on Cemex SAB de CV (CX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Cemex SAB de CV (NYSE:CX)

Receive News & Ratings for Cemex SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cemex SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.